Weakness in Abilify - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Weakness, when it was recovered, drug effectiveness, race, and more among people who take Abilify (aripiprazole). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,447 Abilify users. Check the latest studies of Abilify.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,573 conditions by eHealthMe. Check the latest studies of Weakness.

On Feb, 07, 2026

30 people who have Weakness while taking Abilify were studied.

Severity of Weakness *:

least: 4.17 %
moderate: 58.33 %
severe: 37.5 %
most severe: 0.0 %

When people recovered from Weakness *:

while on drug: 6.67 %
after off the drug: 0.0 %
not yet: 93.33 %

Effectiveness of Abilify *:

not at all: 16.67 %
somewhat: 29.17 %
moderate: 37.5 %
high: 12.5 %
very high: 4.17 %

Race of the people *:

African American, Non-Hispanic: 3.7 %
American Indian/Alaska Native: 0.0 %
Asian: 3.7 %
Hispanic: 3.7 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 88.89 %

Time on Abilify *:

Gender of people when taking Abilify *:

female: 70 %
male: 30 %

Age of people when taking Abilify *:

Conditions people have *:

Insomnia (sleeplessness): 5 people, 16.67%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 10.00%
Stress And Anxiety: 3 people, 10.00%
Urge Incontinence (urinary incontinence): 2 people, 6.67%
Migraine (headache): 2 people, 6.67%
Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 2 people, 6.67%
Birth Control: 2 people, 6.67%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 2 people, 6.67%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 2 people, 6.67%
Sleep Disorder: 2 people, 6.67%

Other drugs people take besides Abilify *:

Other side effects people have besides Weakness *:

Fatigue (feeling of tiredness): 7 people, 23.33%
Agitation (state of anxiety or nervous excitement): 4 people, 13.33%
Headache (pain in head): 3 people, 10.00%
Memory Loss: 2 people, 6.67%
Confusional State: 2 people, 6.67%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 6.67%
Nausea And Vomiting: 2 people, 6.67%
Nausea (feeling of having an urge to vomit): 2 people, 6.67%
Breathing Difficulty: 2 people, 6.67%
Movement - Uncoordinated: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Weakness?

Check whether Weakness is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Weakness in Abilify

How the study uses the data?

The study is based on aripiprazole (the active ingredients of Abilify). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.